logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Covidien (COV) Paying $680 Million for Camera-in-a-Pill Maker Given Imaging (GIVN)

By  +Follow December 9, 2013 7:38AM
Share:
Tickers Mentioned:

Medical device manufacturer Covidien plc (COV) said Sunday that it is buying medical technology company Given Imaging Ltd. (GIVN) in a transaction valued at $860 million to expand its gastrointestinal diagnostic business. The news came after three units of Nochi Dankner’s IDB group agreed Saturday to sell their positions in Given Imaging, although the name of the buyer was not disclosed.

Covidien, which is headquartered in Dublin, Ireland, said it will pay $30 per share for Israel-based Given, representing about a 27-percent premium to Friday’s closing price of $23.65 per share of GIVN. The boards of both companies have approved the acquisition, which is expected to close by the end of March 2014.

Capsule Endoscopy

Given Imaging is a pioneer in capsule endoscopy. The company has developed PillCam, an ingestible capsule containing a tiny camera that when swallowed allows clinicians to look inside, and monitor and diagnose the digestive system as an alternative to a traditional endoscopy. Given has been under pressure for nearly two years to sell itself, including investor Discovery Group urging the company in October to initiate a $50 million share buy-back plan and put itself on the auction block again, saying it is chronically undervalued because of poor management. At that time, Discovery Group, which owns about 4 percent of Given Imaging, thought the company could get an offer of up to $30 per share. Looks like it was right.

Covidien said that it will use cash on hand to fund the purchase. Given Imaging will report within the medical devices segment of Covidien and is expected to add between $40 million to $50 million per quarter in incremental revenue to the division. From profit and operating margin standpoints, the acquisition is not expected to be accretive until fiscal 2015.

A Strong Q3 for Given Imaging

During the third quarter ended September 30, Given Imaging generated $50 million in sales, up 10 percent from the year prior quarter. Adjusted earnings were $8.2 million, or 25 cents per share, up 4 percent from Q3 2012. Global PillCam sales increased 9 percent during the quarter to 63,500 capsules. Worldwide sales of GI diagnostics products improved by 15 percent to $15.3 million. By integrating the Given Imaging operations, Covidien will be able to leverage its global reach to further bolster sales of Given’s products.

“We believe GI is one of the most attractive specialty procedure areas. Acquiring Given will enable Covidien to significantly expand its presence in a $3 billion GI market,” said Bryan Hanson, Group President, Medical Devices & U.S., Covidien, in a statement today.

“After thoroughly evaluating our strategic options we determined that this transaction is in the best interests of Given Imaging, its shareholders and employees and provides unique benefits to patients globally,” added Homi Shamir, president and chief executive at Given Imaging Ltd.

Shares of GIVN jumped ahead to near the buyout price at the opening bell. Through Friday’s close, the stock price was up about 33 percent in 2013. Shares of COV, which were up 28 percent in 2013 through Friday, have inched up about half a percent in Monday morning action to $68.48.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for COV
ProVesting
27 Feb 15 15:10:02
$COV: New SEC Filing for COV: Form 15-12G (No. 0001193125-15-070280): http://t.co/KDRY47pcsV
SEC Filings
27 Feb 15 15:09:06
NEW SEC Filing for $COV filed a moment ago: http://t.co/Qe5DHob2yH http://t.co/2XGFChkL4Q
Market Realist
27 Feb 15 13:29:21
Highlights of Elliott Management’s 4Q14 positions $AGN $CBST $COV $INFA http://t.co/xxImVCB5ui
DailyStockPicks
27 Feb 15 11:21:36
After large gain on $EYES, $KBIO is next with $1 in net cash $CMCSA $COV $PBR $PRU $MRO $DFS investors read http://t.co/t2YAvyw70P
Irma Doucet
27 Feb 15 08:31:49
$COV Brokerages Set Covidien plc Target Price at $90.60 (NYSE:COV) http://t.co/C74piPAftN
James P Worthy
27 Feb 15 05:05:50
$COV Brokerages Set Covidien plc Target Price at $90.60 (NYSE:COV) http://t.co/uvCDCFiWS1
Bob Holtsman
26 Feb 15 13:03:57
RT @HedgeMind: George Soros' new buys: $LYB $ENDP $LC $AGN $SLXP $RLGY $DVN $CLR $COV $CBST $JUNO $BLCM http://t.co/2hC4IGPCqi http://t.co…
Befree
26 Feb 15 12:34:08
RT @HedgeMind: George Soros' new buys: $LYB $ENDP $LC $AGN $SLXP $RLGY $DVN $CLR $COV $CBST $JUNO $BLCM http://t.co/2hC4IGPCqi http://t.co…
HedgeMind
26 Feb 15 12:31:58
George Soros' new buys: $LYB $ENDP $LC $AGN $SLXP $RLGY $DVN $CLR $COV $CBST $JUNO $BLCM http://t.co/2hC4IGPCqi http://t.co/PHD1eiHn0K
Lucretia
26 Feb 15 10:02:56
$COV Announcement under Irish Takeover Rules -- Results of Covidien plc's ... http://t.co/an2cB3NAAZ
2iQ Research
26 Feb 15 08:14:54
Using Insider Buying to Navigate Special Situations: Boston Scientific Corp $BSX Covidien plc $COV via @CatalystMF http://t.co/WdtwmUDOut
John Ablemann
26 Feb 15 06:01:22
$COV Brokerages Set Covidien plc Target Price at $90.60 (NYSE:COV) http://t.co/XRO3wd4ARk
SmallCaps
25 Feb 15 22:00:27
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Breaking News
25 Feb 15 11:15:02
$COV: Interview - Patience Pays Off For Medtronic's Solitaire: http://t.co/afDtdDwEdo
Daily Contracts
25 Feb 15 05:28:00
Real-Time feed of company contracts, original agreements and executive updates from $COV http://t.co/7sENsa9W9J
SmallCaps
24 Feb 15 22:23:02
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqurh3 $RFMD $IYT $MERC $GASL $COV $RH
Clair Voight
24 Feb 15 12:30:56
$COV Chilton Investment Company raises its stake in Covidien plc http://t.co/g1uDfjsL7Y
Harry Walkman
24 Feb 15 12:30:54
$COV Medtronic Completes Covidien Acquisition for $50B http://t.co/Lj5e1trJ0Q
Varun Saxena
24 Feb 15 09:38:01
Medtronic/Covidien - FierceMedicalDevices: http://t.co/79uGrUCUHI $MDT $COV
medtech[y]
24 Feb 15 09:36:02
Flashback Thread: Great conversation on PillCam and their acquisition by @Covidien |http://t.co/iUqcjGto0N @GivenImaging $COV
Samuel Brown
24 Feb 15 09:31:37
$COV Medtronic Completes Covidien Acquisition for $50B http://t.co/NKfGuennG8
chartguy89
24 Feb 15 09:27:02
COV -0.79% Stock Charts $COV Covalon Technologies Ltd. (CVE) Last Updated: 02/24/2015 11:27:06 COV Stock Chart http://t.co/l2h8KiPCmb
DailyStockPicks
24 Feb 15 08:53:18
$EYES is up 20% today after successfully restoring vision to blind patients. $25+ tgt $CMCSA $COV $PBR investors read http://t.co/OSr6rq0DgY
WKRB News
24 Feb 15 06:09:40
Covidien plc Given Consensus Recommendation of “Hold” by Analysts $COV http://t.co/hb2JrwK7vL
SmallCaps
24 Feb 15 05:23:56
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Penny Stock Secret
23 Feb 15 22:53:42
This Guy Turned $100 Into Over $10,000 In Just 30 Days!!! http://t.co/NovWYe2RAx .. $COV $CP $CPA
PennyStock Zone
23 Feb 15 11:39:06
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/HMYdF92FUf $RFMD $IYT $MERC $GASL $COV $RH
SogoTrade
23 Feb 15 08:36:49
SogoTrade’s Morning Call on Today’s Spotlight Stocks $VRTX, $COV, $EEM, $EWY,$TGT,$RTN$STVhttp://www.sogotrade.com/landing/SogolandTC.asp
SogoTrade Options
23 Feb 15 08:36:23
SogoTrade’s Morning Call on Today’s Spotlight Stocks $VRTX, $COV, $EEM, $EWY,$TGT,$RTN$STVhttp://www.sogotrade.com/landing/SogolandTC.asp
SmallCaps
22 Feb 15 01:03:46
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Dan
21 Feb 15 20:33:28
@hedgefundclone Co owner Noah Levy was former Goldman analyst. Up 98% in $COV position and 72% in $NWS
Dakota Financial
21 Feb 15 13:47:25
Brokerages Set Covidien plc Target Price at $90.60 $COV http://t.co/DLBeL8nz8r
Beverage Consulting
21 Feb 15 05:32:28
RT @stockroads: $ABC, $AET, $AVGO, $BABY, $BSX, $CMN, $COV, $DPS, $ED, $GPK, $JNS, $MDT, $MNST, $NQ, $OAS, $ROST, $TSCO, $VRTX, weekly revi…
SmallCaps
20 Feb 15 18:15:55
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
FinanzLinksUSA
20 Feb 15 16:01:50
RT @IPOtweet: Gulp: Imaging capsule maker Check-Cap prices IPO at $6, the low end of the range $CHEK $COV $IPO #IPO http://t.co/vf8JH3QpvK
TalkMarkets
20 Feb 15 14:20:33
Goldman’s Hedge Fund VIP List: 50 Stocks That Matter Most $BRKB $YHOO $BABA $ACT $AAPL $AGN $COV $FB $AAL $C $BIDU http://t.co/mQN2O5LCwd
Karan Chandidas
20 Feb 15 09:58:25
RT @NatalieGrover: #FDA approves Covidien's device to permanantly treat #varicose #veins (http://t.co/GooeWeyx3D) $COV $MDT
Natalie Grover
20 Feb 15 09:10:19
#FDA approves Covidien's device to permanantly treat #varicose #veins (http://t.co/GooeWeyx3D) $COV $MDT
Shweta
20 Feb 15 07:58:25
.@Medtronic Balance Sheet Overburdened By @Covidien: Gimme Credit $MDT $COV http://t.co/ZIYCpYVuTG | Via @barronsonline
Traderinvestor
20 Feb 15 06:08:15
RT @HedgeMind: Soros's Notable healthcare new picks: $ENDP $AGN $SLXP $COV $CBST, exited $SYK $ABBV. Also jumped on $ZTS train. http://t.co…
HedgeMind
20 Feb 15 05:35:20
Soros's Notable healthcare new picks: $ENDP $AGN $SLXP $COV $CBST, exited $SYK $ABBV. Also jumped on $ZTS train. http://t.co/2hC4IGPCqi
Irma Doucet
20 Feb 15 05:02:16
$COV Announcement under Irish Takeover Rules -- Results of Covidien plc's ... http://t.co/NsR2srRoQw
				
				
By  +Follow December 9, 2013 7:38AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.